National cancer policy comes into force in the SUS and expands the supply of advanced therapies and vaccines

Patients across the country will have access to more comprehensive cancer prevention and control protocols on Sistema Único of Saúde (SUS). Lei nº 15,385, published in Diário Oficial of União on Monday, May 13th, establishes Política Nacional of Prevenção and Controle of Câncer within the scope of the SUS and Programa Nacional of Saúde0 of Saúde1 with Saúde2 of Saúde3.
This initiative aims to modernize the healthcare system, ensuring the incorporation of significant innovations, such as advanced therapies, new vaccines and more effective diagnostic tests. The rule was made official by the president Luiz Inácio Lula of Silva and by the minister of Saúde, Alexandre Padilha, in a ceremony held on Friday, May 10, during the inauguration of Centro of Ensino, Simulação and Inovação (Cesin) of Instituto of Coração (InCor), of Silva0 of Silva1 of Silva2 of Silva3. legislation represents a crucial advance for public cancer treatment.
New Política and Navegação from Pacientes
The creation of Política Nacional of Prevenção and Controle of Câncer has as one of its pillars the organization of a more robust and efficient care network for oncology patients. Ela sets clear guidelines for the patient journey, from early diagnosis to treatment and ongoing follow-up. The central objective is to standardize and optimize care flows, reducing barriers and waiting times, which are often critical for the prognosis of the disease. The law also emphasizes the importance of humanizing treatment and providing comprehensive support to patients and their families.
At the same time, Programa Nacional of Navegação of Pessoa with Diagnóstico of Câncer appears as a fundamental support mechanism. Este program aims to offer personalized support to patients, guiding them on the next steps, procedures and rights within the SUS. Navigation helps mitigate misinformation and anxiety, connecting the patient to the resources they need and ensuring they don’t get lost in the complex healthcare system. The proposal is to ensure that each individual receives adequate care in a timely manner, promoting better adherence to treatment and, consequently, better clinical results.
Incentive to Inovação and Produção Nacional
The new law addresses the need to reduce external dependence on essential technologies and supplies in the fight against cancer. The legal text provides for a series of principles and guidelines focused on strengthening the national industrial and technological base. By stimulating local production, Brasil seeks to ensure the continuous availability of medicines, vaccines and equipment, making the healthcare system less vulnerable to international market fluctuations and global supply crises. Esta measure has the potential to generate a virtuous cycle of scientific and economic development.
The main points governing the production and health regulation of cancer technologies within the scope of the policy are:
- Reduced dependence on imports of strategic inputs and technologies.
- Encouragement of technology transfer between research institutions and companies.
- Encouraging the formation of public-private partnerships for development and production.
- Valorization of national production of medicines, vaccines and equipment.
- Technological training of professionals and generation of innovation in the sector.
Furthermore, the legislation encourages the creation of biotechnology startups specifically focused on developing vaccines and oncology medicines. Há also strong support for the application of artificial intelligence in research activities, aiming to accelerate discoveries and optimize diagnostic processes. Encouraging the adoption of large-scale genetic sequencing, in turn, promises to advance personalized medicine, allowing for more targeted and effective treatments based on the patient’s and tumor’s genetic profile.
Access Universal to Tratamentos Avançados
One of the pillars of Lei nº 15,385 is the guarantee of universal and equal access to all technologies and procedures related to cancer. Isso includes not only conventional treatments, but also vaccines, innovative medicines and advanced therapy products. The free nature of these resources is a central point, ensuring that cost is not an impediment to the patient receiving the best care available. The law reinforces the premise that health is a right for everyone and a duty of Estado.
In addition to the availability of resources, the policy foresees the promotion of robust health education strategies. Essas actions aim to inform the population about prevention, early detection and patients’ rights, enabling them to seek help and actively participate in their own treatment. The law also establishes clear criteria for verifying the potential therapeutic response of each treatment, ensuring that interventions are based on solid scientific evidence and that resources are used more effectively, always aiming for the direct benefit of the patient.
Expanding access to innovative treatments is another crucial point. The text highlights that the SUS must follow advances in science, incorporating new therapies that demonstrate efficacy and safety. Esta incorporation will be carried out in a transparent and well-founded manner, with rigorous evaluations. Strengthening partnerships with national and international universities and research centers is essential for Brasil to be at the forefront of oncological knowledge, translating scientific discoveries into concrete benefits for patients in the public system.
Scenario Atual from Câncer on Brasil
Cancer represents one of the biggest public health challenges in Brasil, with millions of cases diagnosed annually and a projected increase in the coming decades, driven by population aging and changes in lifestyle habits. Oncological diseases are the second leading cause of death in the country, behind only cardiovascular diseases. Dados Epidemiological experts point to the continued need for investment in prevention, early diagnosis and cutting-edge treatment.
Despite advances in medicine, the public health network still faces significant challenges, such as inequality in access between different regions of the country and long queues for diagnostic and therapeutic procedures. The lack of specialized infrastructure and the shortage of professionals in some locations compromise the quality and agility of service. The new law seeks precisely to mitigate these gaps, promoting greater equity and more agile and qualified care for all Brazilians facing the disease.
Next Passos and Expectativas
The effective implementation of Lei nº 15,385 will require a coordinated effort between Ministério of Saúde, state and municipal departments, hospitals and research centers. The regulation of various points of the law will be crucial for its practical application, defining deadlines, responsibilities and financing mechanisms. Espera It is expected that, in the coming months, detailed plans for the operationalization of Política Nacional of Prevenção and Controle of Câncer and Programa Nacional of Navegação will be released.
The medical community and patients eagerly await the concrete impacts of the new legislation. The modernization of the SUS in the oncology field is not limited only to the incorporation of new technologies, but also to the optimization of management processes and the continued training of health professionals. Inspection and constant monitoring will be essential to ensure that the principles and guidelines of the law are effectively complied with, transforming the reality of cancer patients in the medium and long term.






